Multiple Sclerosis (now Multiple Sclerosis Journal)

Multiple Sclerosis (continued as Multiple Sclerosis Journal under SAGE) is the leading peer-reviewed journal for multiple-sclerosis research worldwide. Founded under Edward Arnold in 1995 with Dame Ingrid V. Allen (Queen's University Belfast) as founding editor, the journal was published by Arnold for eleven years before being transferred to SAGE Publications in the 2006 Hodder Arnold journal-list sale.

Editorial scope covers the full MS research landscape: pathogenesis and neuroimmunology (demyelination, remyelination, neuroinflammation, the role of B cells and microglia), neuroimaging biomarkers (MRI, OCT), the clinical neurology of MS (relapsing-remitting, secondary-progressive, primary-progressive disease courses), disease-modifying therapy (the explosion of approved DMTs from interferons in the mid-1990s through current high-efficacy agents), symptomatic management, neurorehabilitation in MS, and the epidemiology and outcomes literature.

Under Ingrid Allen's founding editorship the journal established itself as the principal MS-specific periodical at a moment when disease-modifying treatment was becoming clinically available, and it continues to play that role under the Multiple Sclerosis Journal masthead at SAGE.